Literature DB >> 10818172

Electrocardiography and 24-hour electrocardiographic ambulatory recording (Holter monitor) studies in children infected with human immunodeficiency virus type 1. The Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV-1 Infection Study Group.

A S Saidi1, D S Moodie, A Garson, S E Lipshultz, S Kaplan, W W Lai, S D Colan, T J Starc, S Shanbhag, K A Easley, J T Bricker.   

Abstract

Limited data are available on the electrocardiogram and ambulatory electrocardiogram recording (Holter) in children infected with the human immunodeficiency virus type 1 (HIV-1). The purpose of this study was to estimate the prevalence and cumulative incidence of rhythm and conduction abnormalities in HIV-1-infected children. Electrocardiograms and Holter monitoring studies were performed annually on 205 HIV-1-infected children enrolled after 28 days of life (group I), 93 HIV-1-infected infants enrolled during pregnancy or during the first 28 days of life (group IIa), and 463 HIV-1-uninfected infants enrolled during pregnancy or during the first 28 days of life (group IIb). The 5-year cumulative incidence in the group I children of second-degree atrioventricular block or supraventricular or ventricular tachycardia was 13.4%, and the 5-year incidence was higher for the older infected group I children (16.8% for children > or =4 years old at first study and 11.4% for children <4 years, p = 0.04). The mean corrected QT interval was also longer for the older infected group I children (p = 0.002) and prolonged in the HIV-1-infected compared to the HIV-1-uninfected group II children (p = 0.02). None of the children had atrial fibrillation or flutter. Arrhythmias are uncommon in children infected with HIV-1 and in children of HIV-1-infected mothers and the arrhythmias identified tend to be benign. Therefore, routine Holter monitoring does not appear to be indicated in asymptomatic children.

Entities:  

Mesh:

Year:  2000        PMID: 10818172     DOI: 10.1007/s002460010038

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  5 in total

1.  The protease inhibitor atazanavir blocks hERG K(+) channels expressed in HEK293 cells and obstructs hERG protein transport to cell membrane.

Authors:  Sheng-na Han; Xiao-yan Sun; Zhao Zhang; Li-rong Zhang
Journal:  Acta Pharmacol Sin       Date:  2015-03-23       Impact factor: 6.150

2.  Usefulness of the pediatric electrocardiogram in detecting left ventricular hypertrophy: results from the Prospective Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2 HIV) multicenter study.

Authors:  Shannon M Rivenes; Steven D Colan; Kirk A Easley; Samuel Kaplan; Kathy J Jenkins; Mohammed N Khan; Wyman W Lai; Steven E Lipshultz; Douglas S Moodie; Thomas J Starc; George Sopko; Weihong Zhang; J Timothy Bricker
Journal:  Am Heart J       Date:  2003-04       Impact factor: 4.749

Review 3.  Cardiac effects in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents: a view from the United States of America.

Authors:  Steven E Lipshultz; Tracie L Miller; James D Wilkinson; Gwendolyn B Scott; Gabriel Somarriba; Thomas R Cochran; Stacy D Fisher
Journal:  J Int AIDS Soc       Date:  2013-06-18       Impact factor: 5.396

4.  Effects of paediatric HIV infection on electrical conduction of the heart.

Authors:  Nikmah S Idris; Michael M H Cheung; Diederick E Grobbee; David Burgner; Nia Kurniati; Mulyadi M Djer; Cuno S P M Uiterwaal
Journal:  Open Heart       Date:  2016-03-10

5.  Association between exposure to Efavirenz and substrates of dysrhythmia in HIV-infected young adults.

Authors:  Zahra Hosseini; Reza Mollazadeh; Seyed-Ali Dehghan-Manshadi; Mehrnaz Mohebi; Masoud Eslami; Seyed-Ali Sadre-Bafghi; Ali Akbari; Saeed Ghodsi
Journal:  Clin Cardiol       Date:  2021-07-30       Impact factor: 2.882

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.